Importance of diagnosing and treating the metabolic syndrome in reducing cardiovascular risk.

Obesity (Silver Spring, Md.)

Volumn 14 Suppl 3, Issue , 2006, Pages

  Smith, Steven R ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER;

CARDIOVASCULAR DISEASE; HUMAN; METABOLIC SYNDROME X; METABOLISM; OBESITY; REVIEW; RISK FACTOR;

ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; OBESITY; RISK FACTORS;

EID: 34247848724     PISSN: 19307381     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2006.292     Document Type: Review

References (28)